SALICYLIC ACID
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 9 个有匹配的监管证据:12 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已解析的物质身份
Salicylic acid
清单限制备注: III/98 V/3
12 个匹配或报告的名称
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 限用 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | Restricted | 2打开记录 1打开记录 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | Restricted | 1打开记录 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | 请查看每条关联记录及其确切条件。 |
| New Zealand NZ | Restricted | 2打开记录 1打开记录 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | Restricted | 2打开记录 1打开记录 2 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条关联记录及其确切条件。 |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Restricted | 1打开记录 1 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | 请查看每条关联记录及其确切条件。 |
| South Korea KR | Restricted | 2打开记录 1打开记录 2 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1打开记录 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条关联记录及其确切条件。 |
| Saudi Arabia SA | Restricted | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
匹配的市场记录和条件
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026Japan
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshotSouth Korea
MFDS Notice 2026-19, effective 18 March 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026附件 II–VI 的精确证据
SALICYLIC ACID
产品范围: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant
最大浓度: (a) 3.0% (b) 2.0% (c) 0.5%
限制: (a) (b) (c) Not to be used in preparations for children under 3 years of age. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product. These levels are inclusive of any use of salicylic acid.
警示语: (a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.
化学身份与性质

Betaine salicylate
- IUPAC 名称
- carboxymethyl(trimethyl)azanium;2-carboxyphenolate
- 分子式
- C12H17NO5
- 分子量
- 255.27 g/mol
- 精确质量
- 255.11067264 Da
- 拓扑极性表面积
- 97.7 Ų
- 氢键供体
- 2
- 氢键受体
- 5
- 共价单元
- 2
- 已定义的立体中心
- 0
又称
另有 4 个已报告名称
外部数据库标识符
- EPA DTXSID:DTXSID60170177
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

(T-4)-Bis(2-(hydroxy-kappaO)benzoato-kappaO)magnesium
Magnesium salicylate is a non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain. It is available in several over-the-counter (OTC) formulations. Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results. — DrugBank
- IUPAC 名称
- magnesium bis(2-carboxyphenolate)
- 分子式
- C14H10MgO6
- 分子量
- 298.53 g/mol
- 精确质量
- 298.0327797 Da
- 拓扑极性表面积
- 121.0 Ų
- 氢键供体
- 2
- 氢键受体
- 6
- 共价单元
- 3
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEMBL:CHEMBL2106755
- EPA DTXSID:DTXSID00889392
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Trolamine Salicylate
Trolamine salicylate is an organic compound or a salt formed between triethanolamine and salicylic acid. Triethanolamine neutralizes the acidity of the salicylic acid. It is a topical analgesic used for temporary relief of minor pain associated with arthritis, simple backache, muscle strains, sprains, and bruises. Unlike other topical analgesics, trolamine salicylate has no distinct odor which improves patient acceptability. It also displays low systemic absorption upon dermal or topical administration and has low skin irritant properties. As with other salicylates, trolamine salicylate is an inhibitor of cyclo-oxygenase (COX) enzymes with no reported selectivity towards a specific enzyme isoform. Trolamine salicylate serves as an active ingredient in topical over-the-counter products for temporary management of mild to moderate muscular and joint pains. — DrugBank
- IUPAC 名称
- 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid
- 分子式
- C13H21NO6
- 分子量
- 287.31 g/mol
- 精确质量
- 287.13688739 Da
- 拓扑极性表面积
- 121.0 Ų
- 氢键供体
- 5
- 氢键受体
- 7
- 共价单元
- 2
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEMBL:CHEMBL2107288
- EPA DTXSID:DTXSID4047969
- PubMed:24312851
- PubMed:19078236
- PubMed:18796932
- PubMed:8876850
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Sodium Salicylate
Sodium salicylate is an organic molecular entity. — ChEBI
- IUPAC 名称
- sodium 2-hydroxybenzoate
- 分子式
- C7H5NaO3
- 分子量
- 160.10 g/mol
- 精确质量
- 160.01363830 Da
- 拓扑极性表面积
- 60.4 Ų
- 氢键供体
- 1
- 氢键受体
- 3
- 共价单元
- 2
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:9180
- ChEMBL:CHEMBL447868
- EPA DTXSID:DTXSID5021708
- PubMed:29117515
- PubMed:23652544
- PubMed:23504962
- PubMed:22898132
- PubMed:21303813
- PubMed:19767084
- PubMed:19173110
- PubMed:19026709
- PubMed:18560754
- PubMed:18483001
- PubMed:17568627
- PubMed:17561093
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Potassium Salicylate
The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Potassium Salicylate... — Cosmetic Ingredient Review (CIR)
- IUPAC 名称
- potassium 2-hydroxybenzoate
- 分子式
- C7H5KO3
- 分子量
- 176.21 g/mol
- 精确质量
- 175.98757550 Da
- 拓扑极性表面积
- 60.4 Ų
- 氢键供体
- 1
- 氢键受体
- 3
- 共价单元
- 2
- 已定义的立体中心
- 0
又称
另有 11 个已报告名称
外部数据库标识符
- ChEMBL:CHEMBL3707342
- EPA DTXSID:DTXSID9060366
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Salicylic acid monoethanolamine
Based on the available information, the CIR Expert Panel concluded that ... MEA-Salicylate... safe as used when formulated to be avoid skin ittiration and when formulated to avoid increasing the skin's sun sensitivity,or, when increased sun sensitivity would be expected, directions for use induce the daily use of sun protection. — Cosmetic Ingredient Review (CIR)
- IUPAC 名称
- 2-aminoethanol;2-hydroxybenzoic acid
- 分子式
- C9H13NO4
- 分子量
- 199.20 g/mol
- 精确质量
- 199.08445790 Da
- 拓扑极性表面积
- 104.0 Ų
- 氢键供体
- 4
- 氢键受体
- 5
- 共价单元
- 2
- 已定义的立体中心
- 0
又称
另有 7 个已报告名称
外部数据库标识符
- EPA DTXSID:DTXSID80208587
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Salicylic Acid
Salicylic acid is a monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. It has a role as an antiinfective agent, an antifungal agent, a plant hormone, a keratolytic drug, an EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor, a plant metabolite and an algal metabolite. It is a conjugate acid of a salicylate. — ChEBI
- IUPAC 名称
- 2-hydroxybenzoic acid
- 分子式
- C7H6O3
- 分子量
- 138.12 g/mol
- 精确质量
- 138.031694049 Da
- XLogP3
- 2.3
- 拓扑极性表面积
- 57.5 Ų
- 氢键供体
- 2
- 氢键受体
- 3
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

Calcium Salicylate
The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Calcium Salicylate... — Cosmetic Ingredient Review (CIR)
- IUPAC 名称
- calcium bis(2-carboxyphenolate)
- 分子式
- C14H10CaO6
- 分子量
- 314.30 g/mol
- 精确质量
- 314.0103289 Da
- 拓扑极性表面积
- 121.0 Ų
- 氢键供体
- 2
- 氢键受体
- 6
- 共价单元
- 3
- 已定义的立体中心
- 0
又称
另有 5 个已报告名称
外部数据库标识符
- EPA DTXSID:DTXSID60890489
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定